Gabelli Dividend & Income Trust Board Intensifies Proxy Defense Against Saba Capital
Summary
The Board of Trustees for Gabelli Dividend & Income Trust is intensifying its proxy battle against activist investor Saba Capital, urging shareholders to vote for the Board's nominees and reject Saba's "Gold" proxy card, citing Saba's "value extractor" tactics and share sales.
Key Events
-
Board Intensifies Proxy Defense
The Board of Trustees issued additional definitive materials to counter activist investor Saba Capital Management in an ongoing proxy contest.
-
Accusations Against Saba Capital
The Board labels Saba a "value extractor" and claims Saba has been selling GDV shares since July 2025, contradicting its stated alignment with shareholders.
-
Warning on Saba's Proxy Card
Shareholders are warned that voting Saba's "Gold" proxy card could disenfranchise them regarding the election of a full slate of trustees.
-
Call to Action for Shareholders
The Board urges shareholders to vote for its nominated trustees using the "WHITE" proxy card and to disregard Saba's "Gold" card.
Analysis
This filing represents a strong defensive maneuver by the Gabelli Dividend & Income Trust's Board of Trustees in its ongoing proxy contest with activist investor Saba Capital Management. The Board explicitly labels Saba as a "value extractor" and highlights Saba's alleged share sales since July 2025, directly challenging Saba's claimed alignment with long-term shareholders. The warning about potential disenfranchisement if shareholders use Saba's proxy card is a critical new argument aimed at protecting the Board's slate of nominees. This escalation underscores the contentious nature of the battle and its potential impact on the fund's governance and future strategy.
At the time of this filing, GDV was trading at $29.21 on NYSE in the Unknown sector, with a market capitalization of approximately $2.6B. The 52-week trading range was $21.82 to $29.46. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.